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TUMOR NECROSIS FACTOR ALPHA SNP VARIANT IN 
PROMOTER REGION G308A, CAUSE PREECLAMPSIA DURING 
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ABSTRACT 
Preeclampsia (PE) is a very common critical condition during pregnancy. As PE is a high-
risk condition during pregnancy, occurring in 25% of all pregnancies, worldwide. In women 
with PE there is an increase in hypertension and albuminuria. Elevated blood pressure can be 
life-threatening after 20
th
 week of pregnancy. Single nucleotide variation in gene sequence 
can be disease causing, among these pathogenic SNPs, a variant in TNF-α, G308A is 
analyzed in many studies as a causative variant to cause preeclampsia. In this case control 
study fifty patients and fifty healthy individuals were enrolled for analysis of TNF-α 
promoter region SNP G308A from Jinnah hospital, Lahore, Pakistan. The genotyping of 
TNF-α (G308A) rs1800629 polymorphisms was performed by PCR-RFLP method. Data 
analysis was performed by using SNPStats, statistical tool. The mean age of all patients and 
controls were calculated, 24.4 ± 6.6 and 25.1 ± 5.3 years, respectively. The frequency of 
G308A polymorphism was more prevalent in the case group, in association with control 
group (p<0.001). There was a significant correlation between inflammation promoting 
genotypes of TNF-α and PE. It can be warily concluded that: TNF- α (G-308A) 
polymorphism can be reflected as a marker of predisposition to preeclampsia in our 
population.  
  
Key words: Preeclampsia, SNP, tumor necrosis factor (TNF), interleukin 1, PCR-RFLP. 
 
Abbreviations: PE: Preeclampsia, SNP: Single Nucleotide Polymorphism, TNF: Tumor 
Necrosis Factor, IL-1: Interleukin 1, MHC: Major Histocompatibility complex, RFLP: 
Restriction Fragment Length polymorphism, EDTA: Ethylenediaminetetraacetic acid, PCR: 




A well-known human pregnancy 
specific syndrome called Preeclampsia 
(PE), which characterizes the occurrence 
of hypertension and significant proteinuria 
in formerly healthy females on or after the 
20
th
 week of gestation (Moodley, 2004; 
Ghulmiyyah et al., 2012). It is a severe 
problem during pregnancy in human with 
prevalence 2-10% worldwide (Molvarec et 
al., 2008). The diagnostic criteria of this 
syndrome are the beginning of 
hypertension, with systolic blood pressure 
more than 140 mmHg, diastolic blood 
pressure is more than 90 mmHg), and 
proteinuria more than 300 mg/24 h 
(Brichant et al., 2014). Pregnant female 
with minor preeclampsia usually are 
asymptomatic however but the women 
with severe preeclampsia (usually Blood 
pressure about 160/110 mmHg) have 
complications like perturbed renal 
function, liver disease, neurological 
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disorders and hematological disturbances 
(Brown et al., 2000). Preeclampsia is a 
clinical condition which causes vascular 
endothelial dysfunction and narrowing the 
arteries that usually happens after twenty 
weeks of gestation and this condition 
persist up to four to six weeks postpartum. 
The clinical presentation is by 
hypertension, in which with pathologic 
edema can either be present or not. It is 
thought that there is controlled maternal 
systematic inflammation occur during 
normal pregnancy during which particular 
proinflammatory cytokines are circulating, 
such as Tumor Necrosis Factor-α, 
Interleukin-6 and Interleukin-1 etc. The 
source of these cytokines is appearing to 
be maternal peripheral blood leukocytes 
and trophoblast (Rusterholz et al., 2007).  
 Healthy normal pregnancy is 
related to a controlled inflammatory 
procedure however, in PE, it gets worse in 
response to excessive placental stimuli (C. 
Redman et al., 2003). It has been 
demonstrated that various cytokines are 
released by white blood cells like 
lymphocytes and those which are linked to 
immune system during pregnancy. Many 
cytokines has been found to be elevated in 
pregnant females with PE which could be 
the possible reason for the development of 
this disorder (Benyo et al., 2008). Levels 
of TNF-α in serum are higher in 
preeclamptic pregnant female then normal 
pregnant females (Benyo et al., 2008). The 
high levels of TNF-𝛼 in serum causative of 
growth, succession, and complications of 
atherosclerosis. It affects the synthesis of 
endothelial nitric oxide synthase (eNOS) 
which results in nitric oxide (NO) 
production resulting endothelial function 
undermined. Physiological induction of 
TNF-α is defensive, but increase in 
production cause direct damage to vascular 
endothelial cell & reduction of regional 
blood flow (Hunt, 1989).  
The genomic position of TNF-α is 
on human chromosome 6p21.3, located 
near the cluster within the class III region 
of major Histocompatibility complex 
(MHC). Many different microsatellite and 
single nucleotide polymorphism (SNPs) 
are important in inflammatory response 
causing preeclampsia. Among all SNPs 
within the TNF-α promoter from which, 
the 308 G to A polymorphism has been the 
studied frequently (Hajeer et al., 2001). 
This study, is designed to analyze the 
polymorphisms within one of the 
candidate gene for preeclampsia i.e. TNF-
α G-308A SNP variant in the promoter 
region. This is a case control study in 
which polymorphism in pregnant females 
with PE has compared with pregnant 
females without PE.  
MATERIALS & METHODS 
 A total of 100 blood samples of 
pregnant women were included in this 
study, in which fifty blood samples were 
having severe PE while other fifty were 
randomly selected having no sign of PE, 
from Jinnah hospital, Johar Town, Lahore. 
The control group of 50 women blood 
sample has no history of hypertension and 
proteinuria during pregnancy and they 
have given birth to healthy fetus of normal 
size and weight also having healthy full 
term gestational age. These samples were 
collected from September 2016 to March 
2018. The Blood samples (5ml) were 
collected from each patient in EDTA vials 
and these were analyzed for all baseline 
diagnostic tests including complete blood 
count (CBC), PTT APTT, (Partial 
thromboplastin time and Activated partial 
thromboplastin time), Hepatitis B and C 
screening in the diagnostic lab of Jinnah 
Hospital, Allama Iqbal Medical College, 
Lahore. 
Extraction of Genomic DNA was 
done by using salting out method (Helms 
et al., 1990). The polymorphism TNF-α 
(G-308A) in the promoter region was 
screened by polymerase chain reaction 
(PCR)-based methods. The set of primers 
used for this purpose is as follows:  
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(Farnaz et al., 2012) 
 The PCR reaction of 25 μl holds in 
PCR buffer (NH₄)₂SO₄, dNTPs 2.5mM, 
MgCl2 25mM, each primer 10µM, Taq 
DNA polymerase 0.1 μl and remaining 
volume made up with distilled water. The 
followed PCR cycle is: denaturation at 
95°C for 2 min, elongation follows 35 
cycles at 95for 1 min, 62 °C for 1 min, and 
finally extension at 72°C for 1 min and 
72for 5 min. The fragment of 117bp was 
obtained after amplification, the 4µl of 
PCR product is mixed with 2µl 
bromophenol blue (dye) prior to loading 
on gel then it was analyzed on 2.0% 
agarose gel stained with ethidium bromide. 
The gel was documented by using Gel Doc 
System (Dolphin). Then the gene clean 
from agarose gel was performed by using, 
DNA recovery kit (Vivantis). For RFLP 
(Restriction fragment length 
polymorphism), the PCR product of TNF-
α (117 bp) were digested with NcoI 
endonuclease (New England biolabs, 
Ipswich, MA, USA).  
 
 
Figure 1: RFLP results, Analysis of TNF-α G-
308A promoter polymorphism in patients with 
preeclampsia; Lane 6: Homozygote for Allele G 
(G/G); Lane 5, 3, 3 & 1: Heterozygote g (G/A); 
M: Ladder 50bp. 17% polyacrylamide gel 
stained with silver nitrate  
 
The protocol of digestion is as 
follows: total reaction of 50µl was 
prepared, for this purpose 5µl 10X NEB 
buffer was added in an eppendorf then 
added 1 µl of restriction enzyme i.e. NcoI, 
then added 10µl of PCR product obtained 
after gene recovery from agarose gel and 
final volume of 50 ul was made up by 
double distilled water. The vial containing 
restriction digestion reaction was 
incubated at 37°C for 30 minutes. The 
polyacrylamide gel (17%) was prepared 
and then resulting digested fragments were 
subject to electrophoresis and then stained 
with silver nitrate. 
RESULTS AND DISCUSSION 
Preeclampsia (PE) is the most 
common serious syndrome during 
pregnancy and is the most common cause 
of pregnancy-induced hypertension and 
proteinuria after the 20
th
 week of gestation. 
During PE, the immune system of mother 
shift towards T-helper type 1, immunity 
where in result, T-lymphocytes produce 
proinflammatory cytokines (Jonsson et al., 
2006).  
TNF-α is a proinflammatory 
cytokine, for this purpose, this study was 
designed to find out the relation between 
TNF-α polymorphism and preeclampsia in 
50 preeclamptic females of Pakistan. This 
was case control study in which subjects 
are pregnant females with preeclampsia 
and controls included females having 
normal health conditions during 
pregnancy. The subject group is with 
elevated blood pressure having mean value 
160.5±5.2 mmHg (systolic blood pressure) 
and in control group was 120.5±6.5 
mmHg. The gestational age of females 
with preeclampsia was 35±1 weeks and 
control group were 36±4 weeks. 
Polymorphism of G308A, in the promoter 
region of the TNF-α gene, was notably 
associated with pre-eclampsia (p -value is 
0.002). The TNF-𝛼 gene, at position 308 
in promoter region i.e. the variant 
genotype (GG + AG) is more ubiquitous in 
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the patient group (52.0, 48.0%) compared 
with controls (86.0, 14.0 %) 𝑃 < 0.001. 
The frequency of the TNF-𝛼 308-GA 
allele was significantly higher in patients 
with preeclampsia than in control subjects 
as shown in tables below: 
 
Table 1: Genotype frequencies of TNF-α (G308A) polymorphism.                                       
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Table 2: Allele frequencies of G308A polymorphism, rs1800629. 
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19 23.9 7 7  
0.002 
 Allele G 
 
81 76.1 93 93 
 
 
The study described, increased 
maternal serum levels of inflammatory 
cytokines, TNF-α in females having PE 
compared with healthy pregnant women as 
mentioned in table 1 and Table 2. Due to 
endothelial damage and endothelial 
dysfunction which results in excessive 
maternal inflammatory response to 
pregnancy by which there was increase in 
serum proinflammatory molecules, 
cytokines, and adhesion molecules which 
were considered as key pathophysiological 
parameters for PE (Redman et al., 2005; 
Laskowska et al., 2007). 
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According to our findings, there is 
a significant correlation between 
inflammation promoting genotypes of 
TNF-α and PE. The result of this study 
showed the high levels in serum of TNF-α 
related with the severity of PE. Complete 
blood count in Women with PE can have 
higher WBCs counts and also high level of 
neutrophils in complete blood picture in 
comparison to normal pregnant group 
(Jaramillo et al., 2001). One of the 
possible mechanisms in PE is the 
endothelial dysfunction in pregnant 
women due to increased production of 
TNF-α which, in turn, result in abnormal 
activation of neutrophils & monocytes. A 
research work in this regard by Sacks et 
al., 1998 wires the elevation in leukocytes 
counts.  
Another study has been done on 
twenty four subjects has shown that high 
levels of TNF-α in plasma of mother has 
high value in contrast with women 
suffering from PE. Another statistical 
analysis based on 160 patients with 
preeclampsia compared to 100 normal 
patients described that TNF-α (G308A) 
allelic frequency are appreciably high in 
women with PE. These findings hold up 
this present study. 
CONCLUSION 
 In this study beside of limitations, 
that is undersized sample size which 
influences the precision of this study, it 
can be warily concluded that: TNF- α SNP 
variant G308A in promoter region can be 
used as a marker of tendency to PE in our 
population. 
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